Your search for supplemental oxygen returned 3 results

Researchers examined the epidemiology and clinical outcomes of sporadic health care-associated respiratory syncytial virus infection in children.

Investigators report findings from a secondary analysis of the DARE-19 trial, which compared dapagliflozin with placebo in patients hospitalized with COVID-19.

Shortly after an EUA was issued, Genentech announced that tocilizumab (marketed under the brand name Actemra) was in shortage.